DENTSPLY SIRONA (NASDAQ:XRAY) Price Target Lowered to $19.00 at Wells Fargo & Company

DENTSPLY SIRONA (NASDAQ:XRAY) had its price objective reduced by research analysts at Wells Fargo & Company from $20.00 to $19.00 in a report issued on Friday,Benzinga reports. The firm currently has an “equal weight” rating on the medical instruments supplier’s stock. Wells Fargo & Company‘s price target indicates a potential upside of 14.87% from the company’s current price.

A number of other equities research analysts also recently issued reports on XRAY. UBS Group reduced their price objective on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating on the stock in a research note on Tuesday, December 3rd. StockNews.com upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research note on Tuesday, February 18th. Jefferies Financial Group lowered DENTSPLY SIRONA from a “buy” rating to a “hold” rating and decreased their price target for the company from $30.00 to $20.00 in a research note on Thursday, January 23rd. Morgan Stanley lowered their price target on DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating for the company in a report on Tuesday, December 17th. Finally, Mizuho initiated coverage on DENTSPLY SIRONA in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $21.00 price objective on the stock. Ten investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $23.58.

DENTSPLY SIRONA Price Performance

NASDAQ:XRAY traded down $0.61 during trading hours on Friday, reaching $16.54. 1,468,230 shares of the company were exchanged, compared to its average volume of 2,430,980. The company has a market capitalization of $3.29 billion, a P/E ratio of -8.00, a P/E/G ratio of 1.80 and a beta of 0.96. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The business has a 50 day moving average of $18.88 and a 200 day moving average of $21.55. DENTSPLY SIRONA has a 1-year low of $16.42 and a 1-year high of $34.91.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of XRAY. Allworth Financial LP lifted its stake in shares of DENTSPLY SIRONA by 40.2% in the third quarter. Allworth Financial LP now owns 2,179 shares of the medical instruments supplier’s stock worth $59,000 after acquiring an additional 625 shares during the period. Wealth Enhancement Advisory Services LLC lifted its position in shares of DENTSPLY SIRONA by 43.9% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 12,038 shares of the medical instruments supplier’s stock worth $326,000 after purchasing an additional 3,671 shares during the period. State of Alaska Department of Revenue lifted its position in shares of DENTSPLY SIRONA by 2.4% in the 3rd quarter. State of Alaska Department of Revenue now owns 23,545 shares of the medical instruments supplier’s stock worth $637,000 after purchasing an additional 560 shares during the period. US Bancorp DE boosted its stake in shares of DENTSPLY SIRONA by 6.0% in the 3rd quarter. US Bancorp DE now owns 59,553 shares of the medical instruments supplier’s stock valued at $1,612,000 after purchasing an additional 3,397 shares during the last quarter. Finally, Cambiar Investors LLC increased its position in shares of DENTSPLY SIRONA by 3.3% during the third quarter. Cambiar Investors LLC now owns 340,234 shares of the medical instruments supplier’s stock worth $9,207,000 after buying an additional 10,862 shares during the period. 95.70% of the stock is owned by institutional investors and hedge funds.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.